Ziyad Kabli is Chief Operating Officer, Middle East & Asia at M42. He is responsible for leading the continued growth of M42’s patient care domains across existing and new markets, while overseeing the renal care business across the region. An accomplished Saudi executive, Ziyad brings more than 20 years of regional and international experience across operations, strategy, and business leadership.
Ziyad joined Diaverum in January 2014 as Managing Director. He began his professional career in 1999 with Unilever in the AMET region, before moving to SADAFCO, a leading Saudi publicly listed company, where he served as an Executive Director.
Ziyad holds a Bachelor of Science in Applied Chemical Engineering from King Fahad University of Petroleum and Minerals (KFUPM) and an MBA in Finance from the American University of Dubai (AUD). He has also completed executive programmes at Duke University’s Sanford School of Public Policy (USA) and Cranfield School of Management (United Kingdom).
